News
Top research at TCT 2018
- Author:
- Catherine Hackett
Mitral interventions studies are set to make the biggest splash.
Audio
CTA radiation, endocarditis breakthrough, ART dangers, and statins
- Author:
- Catherine Hackett
Listen to the week’s top news on Cardiocast.
Video
Lorcaserin shows CV safety in CAMELLIA-TIMI 61
- Author:
- Catherine Hackett
It’s the first weight-loss drug ever to show cardiovascular safety, Dr. Erin Bohula said in an interview.
Video
Lorcaserin shows CV safety in CAMELLIA-TIMI 61
- Author:
- Catherine Hackett
It’s the first weight-loss drug ever to show cardiovascular safety, Dr. Erin Bohula said in an interview.
News
New guidelines remap adult congenital heart disease
- Author:
- Catherine Hackett
Also, how mammograms may help coronary artery disease prevention, why dietary variety doesn’t translate to quality, and how PCI can tackle complex...
Audio
Blood pressure control prevents cognitive impairment
- Author:
- Catherine Hackett
Plus, does omega-3 supplementation do any good for the heart?
Audio
Analysis shows ‘Devil’s bargain’ in cardiac arrest
- Author:
- Catherine Hackett
TAVR recommendations get a reboot, federal documentation requirements may see big reductions, and more in MDedge...
News
ADA punts photography ban to presenters
- Author:
- Catherine Hackett
After fierce backlash from last year’s photography ban, the ADA is letting presenters decide whether to allow...
Video
ODYSSEY Outcomes results build on FOURIER
- Author:
- Catherine Hackett
ODYSSEY Outcomes proves benefit of PCSK9 inhibition, but small differences from FOURIER are concerning.
Video
Post-ACS death lowered in ODYSSEY Outcomes
- Author:
- Catherine Hackett
ORLANDO – Mortality and major adverse cardiovascular events were cut 15%, but that’s not all.
Article
Test storyHeadline – 7 words, sentence case, active verb, include best SEO terms
- Author:
- Catherine Hackett
DATELINE (USE CAPS LOCK) – Text Normal this is a hyperlinkemail address On Twitter